| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.32 | 1e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0009 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.002 |